Seladelpar: an investigational drug for the treatment of early-stage primary biliary cholangitis (PBC)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Seladelpar: an investigational drug for the treatment of early-stage primary biliary cholangitis (PBC)

Published:2022-10-03 Issue:10 Volume:31 Page:1101-1107
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Wetten Aaron¹²,Jones David Emrys Jeffreys¹²,Dyson Jessica Katharine¹²

Affiliation:

1. Translational and Clinical Research Institute, Newcastle University, Newcastle-upon-Tyne, UK

2. Liver unit, Freeman Hospital, Newcastle-upon-Tyne, UK

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543784.2022.2130750

Reference55 articles.

1. Primary biliary cirrhosis

2. Primary biliary cirrhosis once rare, now common in the United Kingdom?

3. Annual report on liver transplantation: Report for 2019/2020. 2020, NHS Blood and Transplant.

4. Sex and Age Are Determinants of the Clinical Phenotype of Primary Biliary Cirrhosis and Response to Ursodeoxycholic Acid

5. The New Epidemiology of Primary Biliary Cirrhosis

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Primary Biliary Cholangitis;Clinics in Liver Disease;2024-02

2. Peroxisome Proliferator-Activated Receptor agonists and antagonists: an updated patent review (2020–2023);Expert Opinion on Therapeutic Patents;2024-02

3. Mechanism-based target therapy in primary biliary cholangitis: opportunities before liver cirrhosis?;Frontiers in Immunology;2023-05-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP